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Abstract: Ten commercially available monoclonal and 
polyclonal anti-A reagents were evaluated for use in the test for 
ABH secretor status after finding unexpected inhibition with a 
monoclonal anti-A (reagent Z). Two of the available monoclonal 
reagents were from different batches from the same clone as 
reagent Z. Those two reagents, as well as reagent Z, appeared to he 
partially neutralized by salivary substances from group A non- 
secretor individuals. This finding suggests that when a saliva inhihi- 
tion test is done, a nonsecretor control saliva of the same ABO 
group as the saliva to he tested should be used. 
Recently, monoclonal antibodies have become 
widely used in immunohematology Such reagents, in 
contrast to polyclonal human reagents, often have a 
narrower specificity and selectivity for their antigenic 
determinants. As a part of our evaluation before intro- 
ducing monoclonal antibodies for routine use, we 
investigated their accuracy in determining the pres- 
ence of salivary group A substance. 
The determination of ABH secretor status by testing 
saliva is generally performed using the lectin anti-H 
(Ulex europaeus) sup(1) for group O individuals and anti-A 
and antiB for non-group O individuals sup(2,3) It is well 
Table 1. 
Anti-A reagents used in test procedures 
known that the anti-A and antiS used for such testing 
should not come from donors who have been hyperim- 
munized to A and B antigens, since alloagglutinins in 
such sera are less susceptible to neutralization.’ 
Materials and Methods 
Four human and five monoclonal anti-A reagents 
were evaluated for use in the test for ABH secretor sta- 
tus (Table 1). 
Saliva and blood samples were collected from 25 
unrelated laboratory staff One sample was from an A, 
Le(a + b -) Indian and one from an AB, Le(a - b +) Chi- 
nese. The remaining samples were from Caucasians. 
All dilutions of saliva and blood grouping reagents 
were made in phosphate buffered saline (PBS), pH 7.3, 
using calibrated pipettes. Dilutions were prepared 
immediately prior to use. 
The presence of salivary group A substances was 
evaluated by inhibition titrations based on previously 
described methods.’ 
Brand 
Code Manufacturer Batch No. Source Names 
1. N Gamma, Houston, TX, USA 5A25-1 Human Omni Series 
2. P Cooper Biomedical Inc., Malvern, PA, USA 231-1 Human 
3. Q Biological Lab, Auckland. New Zealand 8668 Human 
4. R Commonwealth Serum Lab, Melbourne, Australia 082/3 Human 
Biotest, Frankfurt. West Germany 13 3046 Monoclonal Seraclone 
1. Biotest, Frankfurt. West Germany 11 1047 Monoclonal Seraclone 
2. V Bioscot, Edinburgh, UK NBF 701 Monoclonal (Sample) 
3. W Eurobio, Germain, Paris, France 028 Monoclonal 
4. X HD Supplies, Aylesbury, UK 534 Monoclonal 
5. Y Ortho, Raritan, NJ, USA BAAIOSC Monoclonal Bioclone 
Z sup(†) Biotest, Frankfurt, West Germany 12 1087 Monoclonal Seraclone 
*Different batches from the same clone as Z. 
‘Results using this reagent in a salivary inhibition test initiated this study. 
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Collection of saliva 
Seven to 10 mL of saliva were collected in a 10-mL 
siliconized vacutainer tube. Within two hours of col- 
lection, the samples were boiled for 10 minutes and 
then frozen at - 30°C. Just before use, samples were 
thawed, centrifuged, and the clear supernates (some 
slightly opalescent) removed for testing. Samples were 
repeatedly frozen and thawed between assays, as this 
procedure has been shown to have no effect on the sta- 
bility of the ABH salivary substances present. sup(4) 
Blood typing 
To determine individual red cell Lewis types, red 
cell samples were tested with three anti-Le sup(a) and three 
anti-Leb reagents of human, goat, and monoclonal ori- 
gin (Biotest [human] anti-Le” 111057 and anti-Leh 
111047, Ortho [goat] anti-Le” LA346A1 and anti-Leh 
LB544A2, and Biotest Seraclone [mouse monoclonal] 
anti-Le” 111037 and anti-Le” 112116). Manufacturers’ 
recommendations for the use of reagents were 
observed. 
Titration of anti-A 
The titers of the different anti-A reagents against 
group A sub(2) red cells using PVC V-bottom microtiter 
plates (No. 001-010-2601, Dynatech Laboratories, USA) 
were determined using PBS for the serial doubling 
dilutions. Three dilutions from each titer, representing 
the last three strong to moderate agglutination read- 
ings, were selected for use in the saliva inhibition test. 
Microtiter plate agglutination was graded using the fol- 
lowing symbols: 
+ = strong agglutination 
w = moderate agglutination 
v = weakagglutination 
- = no agglutination 
Salivary inhibition test method 
Saliva samples, serially diluted in PBS, were pre- 
pared in microtiter plates by placing 20 µL of appropri- 
ate saliva dilutions into the wells. The microtiter plates 
were frozen and stored at - 30°C and thawed immedi- 
ately prior to use. Twenty µL of the appropriate dilution 
of blood grouping reagent (anti-A) were added to wells 
of the microtiter plate containing the selected saliva 
dilutions, and the mixtures were allowed to react at 
room temperature. After 30 minutes, 20 µL of a 2 per. 
cent suspension of group A sub(2) red cells were added and 
the reactants allowed to incubate for 60 minutes at 
room temperature. The microtiter plates were 
inclined at an angle of 45 degrees on an illuminated 
view box and allowed to settle for three minutes; 
agglutination was graded within the following five 
minutes. 
Screening tests 
Initially, all saliva samples were serially diluted from 
1:1 to 1:8 and tested with monoclonal anti-A (reagent 
Z), which had previously been found to give unex- 
pected results with group A, Le(a + b -) samples. The 
saliva samples were then diluted 1:2 and tested against 
10 more anti-A reagents, including 2 (S, T) from the 
same clone as Z. Finally, the three salivas from group A 
nonsecretors and positive and negative inhibition con- 
trol salivas were each diluted from 1:2 to 1:16 and 
tested against the three dilutions selected from the 
titration results of the anti-A reagents listed in Table 2. 
Microplate technology control 
To confirm the accuracy of the microplate technol- 
ogy, positive and negative inhibition controls and 
three group A, Le(a + b -) saliva samples were retested 
by the tube technique against dilutions one, two, and 
three selected for reagents R, S, and T (Table 2). 
Results 
Red blood cell Lewis types of the 25 saliva 
donors 
The 25 Lewis types were as follows: Group 0: 3 
Le(a+ b -), 9 Le(a - b +), 1 Le(a - b -); group A: 3 
Le(a + b -), 6 Le(a - b +); group B: 1 Le(a - b +); group 
AB: 1 Le(a + b -), 1 Le(a - b +). 
Reagent anti-A titers 
Table 2 shows the results of titrations performed on 
the four human (polyclonal) and five monoclonal 
anti-A reagents. Titration endpoints ranged from 1:32 
to 1:512 with the highest titers seen with the 
monoclonal reagents. Table 2 also lists the three serial 
dilutions selected for each reagent used in salivary 
inhibition tests. 
Saliva inhibition screening tests 
The initial saliva inhibition screening test, per- 
formed with saliva samples diluted from 1:1 to 1:8 and 
dilution one (see Table 2) from the anti-A reagents, 
showed that the seven A and AB secretor salivas inhib- 
ited all the reagents; the 15 group O and B saliva sam- 
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Monoclonal anti-A and saliva inhibition tests 
Secretor Blood Saliva 
status groups dilution 
Secretor A Le(a-b+)* 1:2 
Nonsecretor 0 Le(a+b-)* 1:2 
Nonsecretor AB Le(a+b-)* 1:2 
Table 2. 
Reagent titers and dilutions used for testing 
Dilution one Dilution two Dilution three 
Human Monoclonal Human Monoclonal Human Monoclonal Test 
N P Q R  S T V W X Y  N P Q R  S T V W X Y  N P Q R  S T V W X Y  status 
Positive control 
salivas 
-  -  -  -  - - - - - - - - - - -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  
+  + ‡ +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  
Negative control 
salivas 
+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  
Anti-A Dilution Dilutions 
Code 0 1 2  1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1,024 One Two Three 




- - - 1:8 1:16 1:32 1. N + t + + + W 
- - - 1:8 1:16 1 3 2  2. P + + + + + W 
- - - 1:8 1:16 1 3 2  3. Q + + + + + W 
- - - 1:8 1:16 1 3 2  4. R + + + + + W 
+ + + + + W W W V - - 1:16 1:32 1:64 
1. + + + + W W W V V - 1:16 1:32 1:64 
v - 1:16 1:32 1:64 2. v + + + + + W W 
1:16 1:32 3. w + + + + + W V V 
4. x + + + + + + W W V V - 1:32 1:64 1:128 






1:8 - - - 
+  +  +  +  v v + + + + + + + + -  -  +  w  +  +  +  w  -  +  -  -  v  -  w  +  Testsalivas 
+  +  +  +  w  +  +  +  +  +  +  +  +  +  v  -  +  +  +  +  + + v + -  -  w  w  +  +  
+  +  +  +  +  +  +  +  +  +  +  +  +  +  w  w  +  +  +  + + v + -  -  +  +  +  +  
+  +  +  +  +  +  +  +  +  +  4 + + + + + + + + + + +  +  w  +  v  -  +  +  +  +  
*Different batches from the same clone. 
Note: Underlined dilutions refer to dilutions one, two, and three 
ples (secretors and nonsecretors) caused no inhibition 
but the three salivas from group A nonsecretors caused 
complete or partial neutralization of reagents S and T, 
representing different batches from the same clone as 
reagent 2. The remainder of the anti-A reagents were 
unaffected (results not shown). 
Confirmatory saliva inhibition test 
To evaluate further the inhibition of anti-A, selected 
control salivas and salivas from the three group A non- 
secretors were diluted from 1:2 to 1:16 and tested 
against the three dilutions of the 9 anti-A reagents 
listed in Table 2. Results are shown in Table 3. 
The group O control sample, as expected, showed 
Table 3. 
Inhibition test results 
no inhibition of anti-A. Control A, Le(a - b +) samples, 
at all dilutions, completely inhibited anti-A. 
Again, group A, Le(a + b -) saliva samples resulted in 
some degree of inhibition of all three dilutions of the 
Biotest monoclonal anti-A reagents (S and T). Using the 
weakest anti-A reagent dilution (No. 3), the group A, 
Le(a + b -) saliva samples were also able to inhibit two 
of the four human (polyclonal) reagents and three 
more monoclonal reagents. The group AB, Le(a + b -) 
sample inhibited none of the reagents. 
Microplate technique controls 
There were no significant differences in the results 
obtained from parallel tests done by the microplate 
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method or the tube test method 
Discussion 
Analysis of these secretor and nonsecretor saliva 
samples indicated that some monoclonal anti-A 
reagents may be neutralized to a marked extent by 
group A nonsecretor salivas. The reagent that was con- 
sistently neutralized consisted of two batches (S, T) 
from the same clone as reagent Z, which provided the 
first clue on which this study was based. 
The ability of the group A, Le(a + b -) samples to 
inhibit the Biotest monoclonal reagents was not a 
result of excessive dilution of the reagents, as the non- 
group-A samples gave very strong reactions at the same 
dilutions. 
Most apparent nonsecretor individuals have been 
reported to secrete small quantities of ABH sub- 
stance~.*,~ Therefore, it is important that nonsecretor 
controls for a secretory assay must all be of the same 
ABO group. Dilution three in Table 3 clearly demon- 
strates the potential error when using non-group-A 
samples, or even group AB samples as controls for 
group A nonsecretors. Using dilution three, the group 
A, Le(a+ b -) samples caused inhibition with half of 
the polyclonal reagents as well as all but one of the rest 
of the monoclonal reagents. This additional inhibition 
is primarily a result of excessive dilution of the 
reagents; however, the group AB and O nonsecretor 
salivas caused no inhibition at that dilution. The dis- 
covery that some monoclonal reagents may be mark- 
edly affected by group A nonsecretor salivas within the 
dilution range recommended for use in an inhibition 
test demonstrates the need for appropriate controls 
and discretion when interpreting results. 
The group A salivary substances found in most 
g r o u p  A nonsecretors are of low molecular weight 
(1,500-13,000 daltons) having a similar antigenic con- 
figuration as the predominantly high molecular 
weight substances (200,000-5,000,000 daltons) of 
secretors. sup(5) It is conceivable that individual monoclonal 
antibodies are capable of specifically interacting with 
these low molecular weight substances and thus be 
neutralized. 
The failure of all monoclonal anti-A reagents to be 
significantly affected by group A salivary inhibition 
may be a consequence of the slightly different specific- 
ity of the different monoclonal reagents for mono- and 
difucosyl-A determinants." One demonstrable differ- 
ence between monoclonal reagents is the ability to 
detect the A, phenotype. There was no correlation in 
this study between the ability to detect this phenotype 
and inhibition of the reagents by group A, Le(a + b -) 
saliva. 
It is unclear why the group AB, Le(a + b -) sample 
failed to show inhibition of the anti-A reagents. It is 
possible that these individuals have lower levels of 
group A substance because of competition for precur- 
sor chains with the group B enzyme, or the salivary 
antigen may be fundamentally different in molecular 
configuration. 
These results emphasize the requirement for non- 
secretor controls in a secretory assay to be of the same 
ABO group as the samples tested. Moreover, the use of 
monoclonal reagents in place of polyclonal reagents 
must be viewed with caution and carefully evaluated. 
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